Natriumchlorid Fresenius Kabi (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid Fresenius Kabi, is an electrolyte presented as a solution for injection for intramuscular, intravenous, and subcutaneous use. It restores extracellular fluid volume and corrects sodium and chloride deficits in patients requiring fluid and electrolyte replacement, such as those with dehydration, surgical losses, or trauma.

GNH USA supplies Natriumchlorid Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and health‑care institutions worldwide. The company adheres to stringent quality standards and ensures reliable global distribution.

Natriumchlorid Fresenius Kabi, a sodium chloride injection, is employed in fluid and electrolyte replacement therapy. - Dehydration: restores extracellular fluid volume and normalizes sodium concentration. - Electrolyte imbalance: replenishes chloride and sodium ions to correct hyponatremia or hypochloremia. - Surgical or trauma fluid loss: provides isotonic solution to maintain circulatory volume during peri‑operative care.

Adverse reactions to Natriumchlorid Fresenius Kabi are generally related to the administration route and electrolyte shifts.

Common Side Effects: - Injection site pain: mild discomfort at the puncture site. - Phlebitis: inflammation of the vein used for infusion. - Mild hypernatremia: transient elevation of serum sodium. - Transient hypertension: slight increase in blood pressure following rapid infusion.

Serious or Rare Side Effects: - Severe hypernatremia: marked rise in serum sodium that can cause neurological symptoms. - Fluid overload: pulmonary edema or heart failure exacerbation in susceptible patients. - Allergic reaction: urticaria, bronchospasm, or anaphylaxis. - Electrolyte imbalance: severe hypokalemia secondary to rapid sodium correction.

Before using Natriumchlorid Fresenius Kabi, clinicians should consider several safety measures. - Assess fluid status: evaluate patient’s volume status and electrolyte profile prior to infusion. - Monitor serum sodium: perform regular laboratory checks during therapy. - Avoid in congestive heart failure: risk of fluid overload and pulmonary edema. - Use caution in renal impairment: reduced excretion may lead to accumulation of sodium. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium chloride solution can interact with other medications affecting fluid balance or electrolyte homeostasis.

Major Interactions (Avoid): - Concurrent hypertonic saline: may cause severe hypernatremia. - Loop diuretics combined with high sodium load: risk of marked electrolyte disturbances.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may potentiate potassium changes when sodium levels shift. - Corticosteroids: can increase sodium retention and fluid volume. - Blood product transfusion: dilutional effect may alter electrolyte concentrations.